As part of our ‘Ask the expert’ series, we heard from neuroscientist and psychiatrist Dr Philip Mosley about the severe impact “behavioural addictions” can have on people with Parkinson’s.
To gain further understanding about why people with Parkinson’s can develop impulsive and compulsive behaviours, Philip contributed to a study which set up a virtual casino for people with the condition. The aim was to explore why some people who take dopaminergic medication struggle with these problems.
“If we can unravel why a problem occurs, or at least explain some of the variability,” he said, “then we can deliver more accurate and personalised information to people with Parkinson’s.” Recognising the added challenges of stigma when it comes to behaviours like gambling, binge eating or hypersexuality, Philip advocates for a “non-judgemental atmosphere” to help people talk freely about these issues.
His advice? “Don’t despair – you can recover from these problems.”
US-based writer Heather Kennedy hadn’t questioned how Parkinson’s might impact her as a woman until she realised how the condition affected menstruation – and she became aware of biased perceptions within the community.
“One thing I’ve noticed in Parkinson’s community is how women are openly shamed for experiencing impulse control disorders to do with sex,” she said. “But when it’s men, you hear that phrase: ‘Boys will be boys’. I just think that dynamic is so wrong.”
Heather herself experienced “hyper compulsion” related to cleaning and shopping. “These drugs are powerful, and they cause major changes in us,” she said. “We need more warning about that.”
These behaviours can manifest in different ways, including “compulsive spending”, says Dr Philip Mosley.
When creating a film about Parkinson’s, UK neuroscientist and writer Jon Stamford knew he wanted to avoid making something too medical or “unfocused”.
“Patients are tired of being lectured to,” he noted. “We wanted to engage with them.” To do this, he partnered with Norwegian filmmaker Anders M Leines to create a series of short films addressing the aspects of Parkinson’s that are rarely discussed openly.
“This lack of discussion, almost a conspiracy of silence, does not serve patients well,” said Jon. “People who suffered from impulse control disorders… can realise that they are not alone, and these aspects can be treated. Openness can only be good.”
When Matt Eagles first started using a ‘dopamine agonist’ (medication which mimics dopamine in the brain), it appeared to be working well. But some 18 months later, he found himself addicted to gambling apps on his phone.
“I’d go to the bathroom just to play on fruit machines, video poker and roulette in secret,” he recalled, “losing the money that my fiancée and I had saved.”
When he admitted the situation to his fiancée, the pair realised he must have been suffering from an impulse control disorder. After seeing a specialist and being weaned off the medication, Matt experienced fewer impulses to gamble. “It was such a relief,” he said.
“The drugs really did help with mobility, so coming off them has meant that my Parkinson’s is worse,” he added. “But it’s a consequence that I’ve learned to live with. The medication was literally ruining my life.”
To learn more about how impulsive and compulsive behaviours can impact people living with Parkinson’s, tune into our upcoming podcast episode on the topic – which will launch on 24 February.
Dopamine agonists for Parkinson’s: a simple introduction
Find out more about Parkinson’s medication
3 weeks ago
Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award
Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…
Study explores predictors of cognitive impairment in Parkinson’s disease
Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.
Could frailty be a potential risk factor for Parkinson’s disease?
Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”